Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinical Pharmacy, İstanbul, Türkiye,
Istanbul, Turkey, 34147, Turkey (Türkiye)
NCT Number: NCT06586333
The study is a prospectively designed, nonrandomized controlled study. It was conducted for six months at the EICU and GICU of a training and research hospital between 1 Jun 2023 and 1 December 2023.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Istanbul, Turkey, 34147, Turkey (Türkiye)
The study involved GICU patients as the standard care services observation group (OG). The use of SUP in the GICU was only monitored and noted. In the EICU, patients were identified as part of the recruiting guideline group (GG), and in addition to receiving usual care, they were managed for SUP according to the ASHP SUP guidelines [1]. The study duration was six months concurrently in the EICU and the GICU. Before inclusion, written informed consent was obtained from each patient or their parent(s)/legal guardian(s). Subjects with incomplete data were excluded. The inclusion criteria were patients aged ≥18 years and hospitalized for ≥24 hours in the EICU/GICU. Patients with a history of stomach cancer, admission to the ICU because of GI bleeding, subtotal/total gastrectomy, or receiving a proton pump inhibitor for therapeutic purposes were excluded from the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the EICU, patients were identified as part of the recruiting guideline group (GG), and in addition to receiving usual care, they were managed for SUP according to the ASHP SUP guidelines
Other names: clinical pharmacist
Time frame: 6 months
% of physician who adhere to ASHP guidelines
Time frame: 6 months
The cost saving by adhere to ASHP guidelines
Altinbas University
Other
Evaluation of the Effect of an Education Program on Reducing the Efficacy and Costs of Inappropriate Stress Ulcer Prophylaxis in Intensive Care Units
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06225167
Digestive System Diseases, Duodenal Diseases
Richardson, Texas, United States
View Trial DetailsNCT02467621
Bacterial Infections, Bacterial Infections and Mycoses
Aalborg, Denmark
View Trial DetailsNCT03553563
Digestive System Diseases, Duodenal Diseases
Bunkyō City, Japan
View Trial DetailsNCT06552624
Acid-dependent Diseases of the Gastrointestinal Tract, Digestive System Diseases
Moscow, Russia
View Trial Details